Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Piroxicam Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
Piroxicam Betacyclodextrine Manufacturers in India Suppliers Piroxicam Betacyclodextrine Exporters Distributors Piroxicam Betacyclodextrine api active pharmaceuticals ingredients Piroxicam Betacyclodextrine manufacturers Side Effects bulk drugs raw material Piroxicam Betacyclodextrine companies Side Effects Importers Piroxicam Betacyclodextrine Piroxicam Betacyclodextrine Exporters Piroxicam Betacyclodextrine exporters FDA Piroxicam Betacyclodextrine DMF Symptoms Generic Taj Pharmaceuticals Ltd. active pharmaceutical ingredients suppliers pharmaceutical Piroxicam Betacyclodextrine manufacturing pharmaceutical drugs pharmaceutical intermediates Piroxicam Betacyclodextrine pharmaceutical chemicals pharmaceutical raw materials Piroxicam Betacyclodextrine active pharmaceutical ingredients Piroxicam Betacyclodextrine committee active pharmaceutical ingredients manufacturer Piroxicam Betacyclodextrine Active Pharmaceutical Ingredients manufacturer Piroxicam Betacyclodextrine exporter drug ingredients pharmaceuticals Pharmaceuticals API Manufacturer Piroxicam Betacyclodextrine, Piroxicam Betacyclodextrine manufacturer India, Piroxicam Betacyclodextrine product, Piroxicam Betacyclodextrine products, Api preparation, Certificate of Analysis API manufacturer product, Piroxicam Betacyclodextrine anti ulcer product, Certificate of Origin COA Piroxicam Betacyclodextrine COS Piroxicam Betacyclodextrine, pharmaceutical generic, pharmaceutical drug, medical, Piroxicam Betacyclodextrine pharma healthcare, pharma patents, contract MSDS manufacturing Trader Piroxicam Betacyclodextrine pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Piroxicam Betacyclodextrine expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Piroxicam Betacyclodextrine DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Piroxicam Betacyclodextrine ingredients, api, HIV Piroxicam Betacyclodextrine, tablets, capsules, syrup & protein Piroxicam Betacyclodextrine powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Piroxicam Betacyclodextrine gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Piroxicam Betacyclodextrine WHO, UKMHRA Approval
   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Pioglitazone left










 








 

 

 

 

HOME >> API >> API List 3 >> Piroxicam Betacyclodextrine >> Interaction

Piroxicam Betacyclodextrine CAS  Number 96684-40-1

INTERACTION

Piroxicam Betacyclodextrine CAS  Number
96684-40-1

Aspirin: When Piroxicam Betacyclodextrine is administered with aspirin, its protein binding is reduced, although the clearance of free Piroxicam Betacyclodextrine is not altered. Plasma levels of piroxicam are depressed to approximately 80% of their normal values when Piroxicam Betacyclodextrine is administered (20 mg/day) in conjunction with aspirin (3900 mg/day). The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of piroxicam and aspirin is not generally recommended because of the potential for increased adverse effects.

Methotrexate: NSAIDs have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices. This may indicate that they could enhance the toxicity of methotrexate. Caution should be used when NSAIDs are administered concomitantly with methotrexate.
Diuretics: Clinical studies, as well as postmarketing observations, have shown that Piroxicam Betacyclodextrine can reduce the natriuretic effect of furosemide and thiazides in some patients. This response has been attributed to inhibition of renal prostaglandin synthesis. During concomitant therapy with NSAIDs, the patient should be observed closely for signs of renal failureWarfarin: The effects of warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION >>
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Piroxicam Betacyclodextrine

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.